Resapp Health Limited (RAP:ASX)

6.5¢

right-arrow Created with Sketch. 0 (0%)
MCAP $55.84M
Last trade 13.31pm 22/10/2021 20mins delayed

Latest Announcements

12/10/2021RAPResapp Health Limited
11/10/2021 Price SensitivePSRAPResapp Health Limited
01/10/2021RAPResapp Health Limited
01/10/2021RAPResapp Health Limited
01/10/2021RAPResapp Health Limited
20/09/2021RAPResapp Health Limited
14/09/2021 Price SensitivePSRAPResapp Health Limited
01/09/2021RAPResapp Health Limited

Company Overview

ResApp Health Limited is an Australia-based company, which is engaged in developing digital healthcare solutions. The Company’s digital healthcare solutions assists doctors and patients to diagnose and manage respiratory disease. The Company has developed a platform for diagnosing respiratory disease using the sound of a patient’s cough. The platform is based on sound alone and does not require physical contact with the patient. With smartphones integrating microphones, the platform can be delivered without the need for additional hardware. The Company has developed smartphone-based machine learning algorithms, which can identify exacerbations in patients with asthma or COPD. It also has ongoing clinical programs investigating the use of these techniques to measure exacerbation severity and lung function. The Company has developed an obstructive sleep aponia screening test that uses overnight breathing and snoring sounds recorded on a smartphone placed on the bedside table.

RAP in the news

ResApp Health (RAP) submits a 510(k) pre-market notification to the US Food…
Digital health company ResApp Health (RAP) expects to receive around $820,000 in…
ResApp Health (RAP) secures two licence agreements with Alodokter and Medgate to…
Mobile healthcare company ResApp Health (RAP) has used the June quarter to…

Search Previous Announcements